| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 890.4K | $40.16M | - | |
| CEO | 875.0K | $39.46M | - | |
| Other | 740.2K | $33.38M | - | |
| 10% | 245.7K | $11.08M | -281,408 | |
| COO | 215.0K | $9.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Kintz Samuel51 | President And CEO | Sell | 12,500 | $21.82 | $272,738.75 | -1.4% | +20.1% | - | |
| Nov 7, 2025 | Patel Anish54 | Chief Operating Officer | Sell | 6,667 | $17.40 | $116,034.16 | -1.2% | +53.1% | - | |
| Oct 20, 2025 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 12,500 | $22.08 | $276,025.00 | -1.3% | +22.3% | - | |
| Oct 17, 2025 | Kintz Samuel51 | President And CEO | Sell | 12,500 | $21.33 | $266,653.75 | -1.4% | +17.6% | - | |
| Oct 7, 2025 | Patel Anish54 | Chief Operating Officer | Sell | 6,667 | $20.10 | $133,992.70 | -2.4% | -24.4% | - | |
| Sep 29, 2025 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 3,250 | $20.40 | $66,291.23 | -12.4% | -21.5% | - | |
| Sep 26, 2025 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 4,000 | $20.25 | $81,005.20 | -0.4% | -18.5% | - | |
| Sep 26, 2025 | Kintz Samuel51 | President And CEO | Sell | 3,700 | $20.06 | $74,227.55 | -0.4% | -18.5% | - | |
| Sep 23, 2025 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 1,500 | $20.03 | $30,045.00 | -0.2% | -6.6% | - | |
| Sep 23, 2025 | Kintz Samuel51 | President And CEO | Sell | 2,800 | $20.03 | $56,084.00 | -0.3% | -6.6% | - |